Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (40)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mas, E.
Right arrow Articles by Sadoulet, M. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mas, E.
Right arrow Articles by Sadoulet, M. O.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Glycobiology, Vol 8, 605-613, Copyright © 1998 by Society for Glycobiology


ORIGINAL ARTICLES

Fucosyltransferase activities in human pancreatic tissue: comparative study between cancer tissues and established tumoral cell lines

E Mas, E Pasqualini, N Caillol, A El Battari, C Crotte, D Lombardo and MO Sadoulet
INSERM-U. 260, Unite de Recherche de Physiopathologie des Regulations Hormono-Nutritionnelles, Faculte de Medecine, 27 Boulevard Jean Moulin, 13385 Marseille-Cedex 5, France.

Human pancreatic cancer is characterized by an alteration in fucose- containing surface blood group antigens such as H antigen, Lewis b, Lewis y, and sialyl-Lewis. These carbohydrate determinants can be synthesized by sequential action of alpha(2,3) sialyltransferases or alpha(1,2) fucosyltransferases (Fuc-T) and alpha(1,3/1,4) fucosyltransferases on (poly)N-acetyllactosamine chains. Therefore, the expression and the function of seven fucosyltransferases were investigated in normal and cancer pancreatic tissues and in four pancreatic carcinoma cell lines. Transcripts of FUT1, FUT2, FUT3, FUT4, FUT5, and FUT7 were detected by RT-PCR in carcinoma cell lines as well as in normal and tumoral tissues. Interestingly, the FUT6 message was only detected in tumoral tissues. Analysis of the acceptor substrate specificity for fucosyltransferases indicated that alpha(1,2) Fuc-T, alpha(1,3) Fuc-T, and alpha(1,4) Fuc-T were expressed in microsome preparations of all tissues as demonstrated by fucose incorporation into phenyl beta-d-galactoside, 2'-fucosyllactose, N-acetyllactosamine, 3'-sialyl-N-acetyllactosamine, and lacto-N-biose. However, these fucosyltransferase activities varied between tissues. A substantial decrease of alpha(1,2) Fuc-T activity was observed in tumoral tissues and cell lines compared to normal tissues. Conversely, the activity of alpha(1,4) Fuc-T, which generates Lewis a and sialyl-Lewis a structures, and that of alpha(1,3) Fuc-T, able to generate a lactodifucotetraose structure, were very important in SOJ-6 and BxPC-3 cell lines. These increases correlated with an enhanced expression of Lewis a, sialyl-Lewis a, and Lewis y on the cell surface. The activity of alpha(1,3) Fuc-T, which participates in the synthesis of the sialyl- Lewis x structure, was not significantly modified in cell lines compared to normal tissues. However, the sialyl-Lewis x antigen was expressed preferentially on the surface of SOJ-6 and BxPC-3 cell lines but was not detected on Panc-1 and MiaPaca-2 cell lines suggesting that several alpha(1,3) Fuc-T might be involved in sialyl-Lewis x synthesis.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
S. R. Barthel, G. K. Wiese, J. Cho, M. J. Opperman, D. L. Hays, J. Siddiqui, K. J. Pienta, B. Furie, and C. J. Dimitroff
Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking
PNAS, November 17, 2009; 106(46): 19491 - 19496.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
L. Benkoel, J.-P. Bernard, M.-J. Payan-Defais, L. Crescence, C. Franceschi, M. Delmas, M. Ouaissi, B. Sastre, J. Sahel, A.-M. Benoliel, et al.
Monoclonal antibody 16D10 to the COOH-terminal domain of the feto-acinar pancreatic protein targets pancreatic neoplastic tissues
Mol. Cancer Ther., February 1, 2009; 8(2): 282 - 291.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
S. R Barthel, J. D Gavino, G. K Wiese, J. M Jaynes, J. Siddiqui, and C. J Dimitroff
Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin
Glycobiology, October 1, 2008; 18(10): 806 - 817.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
Z. Kyselova, Y. Mechref, P. Kang, J. A. Goetz, L. E. Dobrolecki, G. W. Sledge, L. Schnaper, R. J. Hickey, L. H. Malkas, and M. V. Novotny
Breast Cancer Diagnosis and Prognosis through Quantitative Measurements of Serum Glycan Profiles
Clin. Chem., July 1, 2008; 54(7): 1166 - 1175.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
M.-O. Sadoulet, C. Franceschi, M. Aubert, F. Silvy, J.-P. Bernard, D. Lombardo, and E. Mas
Glycoengineering of {alpha}Gal xenoantigen on recombinant peptide bearing the J28 pancreatic oncofetal glycotope
Glycobiology, June 1, 2007; 17(6): 620 - 630.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
N. Tokuda, Q. Zhang, S. Yoshida, S. Kusunoki, T. Urano, K. Furukawa, and K. Furukawa
Genetic mechanisms for the synthesis of fucosyl GM1 in small cell lung cancer cell lines
Glycobiology, October 1, 2006; 16(10): 916 - 925.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
W. Chen, J. Tang, and P. Stanley
Suppressors of {alpha}(1,3)fucosylation identified by expression cloning in the LEC11B gain-of-function CHO mutant
Glycobiology, March 1, 2005; 15(3): 259 - 269.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
R. Peracaula, L. Royle, G. Tabares, G. Mallorqui-Fernandez, S. Barrabes, D. J. Harvey, R. A. Dwek, P. M. Rudd, and R. de Llorens
Glycosylation of human pancreatic ribonuclease: differences between normal and tumor states
Glycobiology, April 1, 2003; 13(4): 227 - 244.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
V Gouyer, E Leteurtre, P Delmotte, W. Steelant, M. Krzewinski-Recchi, J. Zanetta, T Lesuffleur, G Trugnan, P Delannoy, and G Huet
Differential effect of GalNAc(&agr;)-O-bn on intracellular trafficking in enterocytic HT-29 and Caco-2 cells: correlation with the glycosyltransferase expression pattern
J. Cell Sci., January 4, 2001; 114(8): 1455 - 1471.
[Abstract] [PDF]


Home page
Cancer Res.Home page
M. Aubert, L. Panicot, C. Crotte, P. Gibier, D. Lombardo, M.-O. Sadoulet, and E. Mas
Restoration of {{alpha}}(1,2) Fucosyltransferase Activity Decreases Adhesive and Metastatic Properties of Human Pancreatic Cancer Cells
Cancer Res., March 1, 2000; 60(5): 1449 - 1456.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. Zhang, B. Potvin, A. Zaiman, W. Chen, R. Kumar, L. Phillips, and P. Stanley
The Gain-of-Function Chinese Hamster Ovary Mutant LEC11B Expresses One of Two Chinese Hamster FUT6 Genes Due to the Loss of a Negative Regulatory Factor
J. Biol. Chem., April 9, 1999; 274(15): 10439 - 10450.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.